Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...
This Idaho health district banned public clinics from distributing the coronavirus vaccine as widespread fear during the ...
1d
KMOV St. Louis on MSNNasal COVID vaccine developed at WashU approved for clinical trialsThe Food and Drug Administration (FDA) recently gave approval for clinical trials in the U.S. of a COVID-19 nasal vaccine ...
11h
What to Expect on MSNShould You Get the COVID-19 Vaccine for Your Baby or Toddler?Is the COVID-19 vaccine safe and effective for infants and young children, and what side effects might kids experience? Here's why it's so important for children to get the COVID-19 vaccine.
A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 ...
Unexpected demand for Pfizer Inc.’s Covid vaccine helped the company beat quarterly expectations. Then Robert F. Kennedy Jr., ...
Fla., praised news that President Donald Trump will reinstate service members expelled for refusing to take the COVID-19 ...
Kentucky officials have reported that the first child of the season has died of influenza as cases rise across the state, ...
R obert F. Kennedy Jr., President Trump’s pick to head the U.S. Department of Health and Human Services (HHS), was grilled by ...
The COVID-19 vaccine confers protection against the development of post-COVID-19 conditions, particularly during the Delta and Omicron eras.
The CDC ACIP recommends 2 doses of the 2024-2025 COVID-19 vaccine for those age 65+ years and 2 or more doses for immunocompromised individuals.
A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results